Profile
Kirk Czymmek is the founder of Peptyde Bio, Inc. and currently holds the title of Director.
Kirk Czymmek active positions
| Companies | Position | Start |
|---|---|---|
Peptyde Bio, Inc.
 Peptyde Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Invaio Sciences, Inc., Peptyde Bio, Inc. is an agtech startup that discovers, designs, and characterizes novel anti-microbial peptides. The company is based in Olivette, MO. These peptides can complement or replace chemical fungicides because they are effective, environmentally friendly, and have a lower cost of development compared to traditional fungicides. The company was founded in 2022 by Dilip Shah and Kirk Czymmek. Peptyde Bio was acquired by Invaio Sciences, Inc. from Danforth Technology Co. on December 07, 2023. | Founder | 01/01/2022 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Peptyde Bio, Inc.
Peptyde Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Invaio Sciences, Inc., Peptyde Bio, Inc. is an agtech startup that discovers, designs, and characterizes novel anti-microbial peptides. The company is based in Olivette, MO. These peptides can complement or replace chemical fungicides because they are effective, environmentally friendly, and have a lower cost of development compared to traditional fungicides. The company was founded in 2022 by Dilip Shah and Kirk Czymmek. Peptyde Bio was acquired by Invaio Sciences, Inc. from Danforth Technology Co. on December 07, 2023. | Commercial Services |
- Stock Market
- Insiders
- Kirk Czymmek
